JNGLX Mutual Fund
JNGLX Mutual Fund
JNGLX Mutual Fund
Janus Henderson Global Life Sciences Fund Class D
JNGLX Mutual Fund Overview
JNGLX Mutual Fund (Janus Henderson Global Life Sciences Fund Class D) is managed by Janus Henderson Investors with $1.45B in net assets. JNGLX expense ratio is 0.81%, holding 98 positions across sectors including Health Care, Financials. Inception date: 1998-12-31.
JNGLX performance shows a YTD return of 14.74%. The 1-year return is 25.30% and the 5-year return is 8.95%. JNGLX dividend yield stands at 0.39%, paid annually.
JNGLX top holdings include Eli Lilly & Co (9.1%), Johnson & Johnson - Common (7.5%), Abbvie Inc. (4.6%), Unitedhealth Group Incorporated (4.3%), AstraZeneca PLC (3.5%). Go to all JNGLX holdings, JNGLX sectors, or JNGLX dividends.
JNGLX can be compared against other funds. Use JNGLX overlap to find shared positions, or JNGLX vs another fund for a side-by-side view. JNGLX alternatives are available via the screener, along with tax-loss harvesting opportunities.